Riskpilot← Back to searchSign inGet full accessMEDICUS ENGINEERING ApS is a Danish APS based in Aarhus N, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2001, the company has 1 employee and reported a gross profit of DKK 1.5m in its latest annual filing.
| Gross profit | 1.5M DKK | +226% |
| EBITDA | 0.8M DKK | +9773% |
| Net profit | 0.5M DKK | +281% |
| Total assets | 6.4M DKK | +3% |
| Equity | -0.1M DKK | +86% |
| Employees | 1 | — |
In its most recent annual report (2025), MEDICUS ENGINEERING ApS reported a gross profit of DKK 1.5m, an increase of 226% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net profit of DKK 522.9k, and the EBITDA margin stood at 50.9%.
At the end of 2025, current assets covered short-term debt 0 times. MEDICUS ENGINEERING ApS is one of 2 companies registered under Research and experimental development on natural sciences and engineering in Denmark.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Gross profit | 1,475 | 452 | 820 | 974 | 391 |
| Staff expenses | -725 | -445 | -727 | -865 | -226 |
| EBITDA | 750 | 8 | 93 | 109 | 165 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -34 |
| EBIT | 750 | 8 | 93 | 109 | 131 |
| Net financials | -267 | -369 | -96 | -228 | -177 |
| Profit before tax | 483 | -362 | -1,102 | -119 | -46 |
| Tax | -39 | -73 | -119 | -146 | -80 |
| Net profit | 523 | -289 | -984 | 27 | 35 |
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 6,375 | 6,180 | 5,648 | 6,021 | 4,829 |
| Equity | -85 | -608 | -319 | 665 | 638 |
| Long-term debt | 2,455 | 2,299 | 1,082 | 1,012 | 955 |
| Short-term debt | 4,005 | 4,490 | 4,885 | 4,345 | 3,236 |
| Total debt | 6,460 | 6,788 | 5,967 | 5,357 | 4,191 |
28 financial ratios from the latest filing, each graded against companies in the same industry.
Net profit as a percentage of total assets — the return generated on the capital employed.
EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.
Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.
The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.
EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.
The profit for the year as a share of revenue — the company's ability to turn revenue into profit.
Net profit as a percentage of equity — the return the owners earned on their invested capital this year.
Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.
Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.
Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.
Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.
Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.
Cash flow relative to profit — the ability to convert reported profits into accessible cash.
Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.
Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.
Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.
Profit relative to debt — the ability to create earnings while operating with debt.
EBITDA relative to debt — how much operating earnings are available to service the debt.
The ability to pay the interest on the company's debt out of its earnings.
Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.
The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.
Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.
Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.
Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.
The size of this year's increase or decrease in the company's debt.
Revenue relative to total assets — the ability to generate revenue from the asset base.
Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.
The size of this year's increase or decrease in the company's equity.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JF Management | Management | 2001 |
MS Founder | Founder | 2001 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
JF Board of Directors | Board of Directors | 2001 |
CF Chairman | Chairman | 2019 |
AG Board of Directors | Board of Directors | 2019 |
TF Board of Directors | Board of Directors | 2019 – 2024 |
JC Chairman | Chairman | 2008 – 2019 |
EC Board of Directors | Board of Directors | 2012 – 2014 |
NE Board of Directors | Board of Directors | 2007 – 2012 |
MS Board of Directors | Board of Directors | 2001 – 2019 |
PE Chairman | Chairman | 2004 – 2008 |
LH Board of Directors | Board of Directors | 2001 – 2007 |
PR Board of Directors | Board of Directors | 2008 – 2010 |
| Shareholder | Type | Ownership | Votes | Registered |
|---|---|---|---|---|
| Company | 20–24.99% | 20–24.99% | 2024 | |
| Individual | 20–24.99% | 20–24.99% | 2024 | |
| Individual | 20–24.99% | 20–24.99% | 2008 | |
| Company | 10–14.99% | 10–14.99% | 2012 | |
| Company | 10–14.99% | 10–14.99% | 2019 | |
| Individual | 5–9.99% | 5–9.99% | 2013 | |
| Individual | 33.33–49.99% | 33.33–49.99% | 2018 | |
| Individual | 10–14.99% | 10–14.99% | 2013 |
MEDICUS ENGINEERING ApS (this company)| Person | Role here | Other companies |
|---|---|---|
| Anders Geert | Board of Directors | 5 companies |
| Lars Henning Stigel | Board of Directors | 4 companies |
| Jesper Fleischer | Management | 2 companies |
| Thomas Fleischer Christiansen | Board of Directors | 2 companies |
| Per Ebdrup | Chairman | 2 companies |
| Christian Fleischer Christiansen | Chairman | 1 company |
| Elon Christensen | Board of Directors | 1 company |
Sparekassen Danmark